ChadDGalderisiDO

Pathology • Portland, OR

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology, Oregon Health and Science University School of Medicine

Join to view full profile

Dr. Galderisi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Galderisi's full profile

Already have an account?

Office
1341 Sw Custer Dr
Portland, OR 97219
Phone+1 503-459-4974
Is this information wrong?

Education & Training

Penn State Milton S Hershey Medical CenterResidency, Pathology-Anatomic and Clinical, 2001 - 2005
Philadelphia College of Osteopathic MedicineClass of 2001

Certifications & Licensure

OR State License 2004 - 2025
MA State License 2012 - 2025
CA State License 2023 - 2025
WA State License 2010 - 2024
PA State License 2001 - 2005
American Board of Pathology Anatomic Pathology
American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

63 citations
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer
David L. Rimm, Samuel C Y Leung, Lisa M. McShane, Yalai Bai, Anita Bane, John M. S. Bartlett, Jane Bayani, Martin C. Chang, Michelle Dean, Carsten Denkert, Emeka K. En...> ;Modern Pathology. 2019 Jan 1
63 citations
Activity of the Fibroblast Growth Factor Receptor Inhibitors Dovitinib (TKI258) and NVP-BGJ398 in Human Endometrial Cancer Cells
Gottfried E. Konecny, Teodora Kolarova, Neil A. O'Brien, Boris Winterhoff, Guorong Yang, Jingwei Qi, Zhengdong Qi, Natarajan Venkatesan, Raul Ayala, Tong Luo, Richard ...> ;Molecular Cancer Therapeutics. 2013 May 1
Angiosarcoma developing after curative induction chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the larynx.
P.J. Gagnon, Chad Galderisi, Brandi R. Page, John M. Holland> ;Head & Neck. 2009 Jun 1
100 citations
A half-log increase in BCR-ABL RNA predicts a higher risk of relapse in patients with chronic myeloid leukemia with an imatinib-induced complete cytogenetic response.
Richard D. Press, Chad D. Galderisi, Rui Yang, Carole Rempfer, Stephanie G. Willis, Michael J. Mauro, Brian J. Druker, Michael W. Deininger> ;Clinical Cancer Research. 2007 Oct 15
19 citations
Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-S.
Mihaela Perić, Biilent Bozdogan, Chad Galderisi, Dan Krissinger, Terry Rager, Peter C. Appelbaum> ;The Journal of Antimicrobial Chemotherapy. 2004 Aug 1
Plasmapheresis in severe forms of myasthenia gravis.
Morosetti, M., Meloni, C., Iani, C., Caramia, M., Galderisi, C., Palombo, G., Gallucci, M. T., Bernardi, G., Casciani, C. U.> ;Artif Organs. 1998 Feb
Join now to see all

Journal Articles

An International Multicenter Study to Evaluate Reproducibility of Automated Scoring for Assessment of Ki67 in Breast Cancer
Richard Levenson, David L Rimm, Daniel F Hayes, Chad Galderisi, Liron Pantanowitz, Nature

Lectures

Development and Validation of a Highly Sensitive e1a2 (p190) BCR-ABL Test to Determine Complete Molecular Response (Minimal Residual Disease Negative) As a Primary End...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Hospital Affiliations

OHSU HospitalPortland, Oregon